Vaccine shown to be cost-effective and trusted by caregivers and health care workers
Vaccine shown to be cost-effective and trusted by caregivers and health care workers
PATH congratulates Gavi, GSK, and MedAccess for joining forces to help ensure an ongoing supply of the first malaria vaccine, RTS,S/AS01E.
Funding from Open Philanthropy Foundation will expand access to RTS,S/AS01 in pilot areas of Ghana, Kenya, and Malawi...
Together with partners and other stakeholders, PATH is working to help ensure sufficient malaria vaccine supply to meet potential demand.